-
Circ_0001084/miR-181c-5p/PTPN4 Axis Mitigates Cardiomyocyte Injury by Modulating the TLR4/NF-κB Pathway: Insights into Therapeutic Potential for Myocardial Reperfusion Injury
22 Jan 2025 09:43 GMT
… of post-transcriptional regulation with therapeutic potential. This integrated, … uncovering additional targets for cardioprotective therapies.
Employing datasets GSE225245 and … Adverse Cardiac Remodeling and Heart Failure Induced by Pressure Overload …
-
Congestive Heart Failure Market Predicted to See Upsurge Through 2034, Highlights DelveInsight
21 Jan 2025 19:40 GMT
… other information for emerging therapies.
Congestive Heart Failure Therapies and Key Companies
• … Heart Failure Therapeutic Assessment: Congestive Heart Failure current marketed and Congestive Heart Failure emerging therapies
• Congestive Heart Failure …
-
Space research offers new hope for heart cell therapy
22 Jan 2025 02:11 GMT
… repair damaged hearts in cell therapy – the process of transplanting … previously been shown to prevent heart failure in preclinical experiments. This … longer in cell-based heart therapy, there could be an … make better cells for cell therapy."
This study was …
-
Cytokinetics Announces Start of AMBER-HFpEF, a Phase 2 Clinical Trial of CK-586 in Patients With Symptomatic Heart Failure With Preserved Ejection Fraction
21 Jan 2025 12:30 GMT
… Approximately half of patients with heart failure have heart failure with preserved ejection fraction … muscle troponin activator with potential therapeutic application to a specific … and competitive products or alternative therapies may be developed by others …
-
SGLT-2 inhibitors’ reimbursement expansion to heart failure patients reignites originality debate
21 Jan 2025 05:33 GMT
… inhibitors to patients with chronic heart failure, upending the related market.
… for treating non-diabetic chronic heart failure patients.
Specifically, SGLT-2 inhibitors … standard therapy” and for “patients with symptoms and signs of heart failure with …
-
Combined Graphene Oxide with 2-Methoxyestradiol for Effective Anticancer Therapy in-vitro Model
21 Jan 2025 18:10 GMT
… therefore be used as anticancer therapeutic systems with relative selectivity, adjustable … possibility of implementing personalised anticancer therapy, which is extremely important, especially … E, et al. Models of heart failure based on the cardiotoxicity of …
-
Heart failure with Reduced Ejection Fraction Market to Expand Significantly by 2032, States DelveInsight Report
20 Jan 2025 21:10 GMT
… , and others
• Heart failure with Reduced Ejection Fraction Therapeutic Assessment: Heart failure with Reduced Ejection … Fraction emerging therapies
• Heart failure with Reduced Ejection Fraction Market Dynamics: Heart failure with Reduced …
-
‘Fatty marbling’ raises risk of heart failure regardless of weight
20 Jan 2025 17:48 GMT
… dying from heart attacks or heart failure regardless of their body … well as future risk of heart failure, heart attack, and death.” … as new weight loss therapies affect fat in the … and muscle-modifying incretin-based therapies”, including weight loss jabs. …
-
Marea Therapeutics Forms Clinical Scientific Advisory Board
21 Jan 2025 13:11 GMT
… diseases such as diabetes, obesity, heart failure and cachexia. Dr. Birnbaum earned … -doctoral cardiovascular research at COR Therapeutics, Millennium Pharmaceuticals and Stanford. …
About Marea Therapeutics
Marea Therapeutics is a clinical-stage …
-
Over 9,000 heart failure patients to benefit from early palliative care under $6.5m programme
20 Jan 2025 17:11 GMT
… years with good medical therapy. Are we saying … .
Under the initiative, heart failure patients are screened for … cardiac symptoms.
Most heart failure patients have basic palliative … addressed by cardiologists and heart failure nurses. These include …